Skip to content
PeptideAgent

Clinics in Vermont

By the PeptideAgent Editorial Team. Draft, pending editorial review.  Last verified

What Vermont law means for peptide clinics: who may prescribe, whether pharmacies may compound GLP-1 drugs (limited), how to check a clinic, and verified listings.

Vermont at a glance

503A framework
Follows the federal 503A framework
Telehealth prescribing
Regulatory: Telehealth allowed
Asynchronous prescribing
Regulatory: Async allowed
Compounded GLP-1 access
Regulatory: Compounded GLP-1 limited

Verified clinics serving Vermont

No verified clinics serving Vermont are listed yet. A provider appears here only after it passes the verification checklist, and those checks are still under way.

Looking for care now? Start with what the law allows where you live, then how a legitimate prescription works.

Run a pharmacy, clinic, or telehealth service? Apply for a listing.

Peptide access rules in Vermont

Yes. A Vermont resident can obtain FDA approved peptides such as semaglutide and tirzepatide from a prescriber authorized to practice in Vermont, including by telemedicine or store-and-forward means under 18 V.S.A. section 9361, and can obtain a compounded peptide when it is eligible under federal 503A rules and dispensed by a drug outlet licensed by the Vermont Board of Pharmacy. Under 26 V.S.A. section 2061 every drug outlet must hold a Board license in the right classification, and compounding is its own license class; Vermont has no state bulks list, so peptide compounding eligibility follows the FDA framework. [1] [2] [3] [4] [5] [6] [7] [8] [9]

Compounded GLP-1 access in Vermont

A pharmacy compounding a GLP-1 for a Vermont patient must hold the appropriate Vermont drug outlet license, including a nonresident license if it ships from out of state. [1] [8] [10]

Research use only sellers in Vermont

Under 26 V.S.A. chapter 36, drugs may be dispensed to Vermont patients only by licensed pharmacists working in licensed drug outlets, so a seller shipping "research use only" injectable peptides to Vermont consumers is not a licensed outlet. [7] [11]

Vermont notes on specific peptides

  • Semaglutide: Available branded by prescription, including from a Vermont-authorized prescriber after a telemedicine or store-and-forward examination under 18 V.S.A. 9361. Compounded semaglutide is limited to the federal patient specific exception since the 503A grace period ended April 22, 2025. [5] [10]

How to check a clinic in Vermont

  1. Confirm the prescribing clinician's license with the Vermont medical or nursing board.
  2. Ask which pharmacy compounds or dispenses the peptide and check it in the Vermont Board of Pharmacy (Office of Professional Regulation, Vermont Secretary of State) license lookup. [1] [2] [3] [7] [8] [9]
  3. Confirm the peptide can be lawfully compounded: check its status on the regulatory tracker or its peptide page before paying.
  4. Walk away from any seller that labels a peptide "research use only" or "not for human consumption". See the research use only section above for what that means in Vermont. [7] [11]

Common questions in Vermont

Can I get a GLP-1 prescription in Vermont through telemedicine?

Yes. 18 V.S.A. section 9361 allows a Vermont-licensed provider to prescribe after an appropriate examination done in person, through telemedicine, or with equipment that transmits images and medical records electronically, held to the same standard as an office visit. [5]

All peptide legal questions for Vermont

Sources

  1. [1]Vermont Board of Pharmacy (Office of Professional Regulation)
  2. [2]Vermont Board of Pharmacy: statutes, rules, and resources
  3. [3]Administrative Rules for the Vermont Board of Pharmacy, effective February 1, 2026 (rules 6-2, 7-4, 10-4, 10-9)
  4. [4]Vermont Office of Professional Regulation
  5. [5]18 V.S.A. section 9361, Health care providers delivering health care services through telemedicine or by store-and-forward means
  6. [6]8 V.S.A. section 4098a, Coverage of health care services delivered through telemedicine and by store-and-forward means (definitions)
  7. [7]26 V.S.A. chapter 36, Pharmacy
  8. [8]26 V.S.A. section 2061, Registration and licensure of drug outlets
  9. [9]FDA: Section 503A of the Federal Food, Drug, and Cosmetic ActFDA
  10. [10]FDA: concerns with unapproved GLP-1 drugs used for weight loss, including shortage resolution and compounding grace periodsFDA
  11. [11]21 U.S.C. 331, Prohibited acts